Nathan J Bryson

Title: Nathan J Bryson: Innovator in Nanoparticle Delivery Systems

Introduction

Nathan J Bryson is a prominent inventor based in Grigny, France, known for his significant contributions to the field of nanoparticle delivery systems. With a total of eight patents to his name, Bryson has focused on developing innovative solutions for the controlled release of active pharmaceutical ingredients.

Latest Patents

Among his latest patents is a colloidal suspension of nanoparticles based on an amphiphilic copolymer. This invention describes an aqueous suspension that remains stable in physiological mediums, designed for delivering active principles such as insulin. The delivery particles utilize a three-block copolymer composed of polyethylene glycol, hydrophilic polyamino acid, and hydrophobic polyamino acid. This unique composition allows for the association of active principles without denaturation, enabling a controlled and prolonged release in vivo.

Another notable patent involves a colloidal suspension of submicronic particles for carrying active principles and their mode of preparation. This invention features biocompatible particles based on a double-block hydrophilic neutral polyamino acid and hydrophobic neutral polyamino acid copolymer. These carrier particles can form stable aqueous suspensions without the need for surfactants or organic solvents, allowing for prolonged and/or delayed delivery of active principles.

Career Highlights

Throughout his career, Nathan J Bryson has worked with several notable companies, including Flamel Technologies and Corning Incorporated. His work has significantly advanced the field of drug delivery systems, particularly in the development of biocompatible materials for pharmaceutical applications.

Collaborations

Bryson has collaborated with esteemed colleagues such as Gérard Soula and You-Ping Chan, contributing to the advancement of innovative technologies in the pharmaceutical industry.

Conclusion

Nathan J Bryson's work in nanoparticle delivery systems exemplifies the intersection of innovation and practical application in medicine. His patents reflect a commitment to improving drug delivery methods, ultimately enhancing patient care and treatment outcomes.